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Abstract
Background: Intellectual disability (ID) is a complex condition that can impact mul-
tiple domains of development. The genetic contribution to ID’s etiology is signifi-
cant, with more than 100 implicated genes and loci currently identified. The majority 
of such variants are rare and de novo genetic mutations.
Methods: We have applied whole‐genome microarray to identify large, rare, clini-
cally relevant copy number variants (CNVs). We have applied well‐established algo-
rithms for variants call. Quantitative polymerase chain reaction (qPCR) was applied 
to validate the variants using three technical replicates for each family member. To 
assess whether the copy number variation was due to balanced translocation or mo-
saicism, we further conducted droplet digital PCR (ddPCR) on the whole family. We 
have, as well, applied “critical‐exon” mapping, human developmental brain tran-
scriptome, and a database of known associated neurodevelopmental disorder variants 
to identify candidate genes.
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1 |  INTRODUCTION
Intellectual disability (ID) is a severe, lifelong neurodevel-
opmental disorder that impacts intellectual capacity and 
adaptive functioning. According to the National Survey 
of Children's Health (NSCH), ID affects about 1.2% of 
children with a spectrum of severity ranging from pro-
found to mild deficits (Maenner et al., 2016). Individuals 
with ID have a higher rate of earlier mortality than the 
population‐at‐large.
ID often co‐occurs with other neurodevelopmental disor-
ders, such as autism spectrum disorder (ASD), attention deficit 
hyperactivity disorder, and epilepsy, and psychiatric disorders, 
such as anxiety, depression, and psychosis (Singh, Singh, Sahu, 
& Tikka, 2018). The prevalence of these mental comorbidities 
among the individuals with ID is as high as 40%. Indeed, a sys-
tematic review found that 30%–50% and 8%–18% of children 
and adolescents with and without an ID, respectively, have a 
mental disorder. Physical health conditions are also common: 
for example, gastroesophageal reflux is seen among 50% with 
ID. Craniofacial dysmorphism may also be observed among 
individuals with ID, such as hypertrichosis, hypertelorism, 
broad nasal bridge, and microcephaly (Iourov et al., 2012). The 
etiology of ID is principally genetic, with an allelic spectrum 
that includes highly penetrant single‐gene mutations, copy 
number variants (CNVs) of variable penetrance, and polygenic 
common variants individually of low penetrance. With more 
than 100 ID genes and loci identified so far, many more remain 
to be discovered (Cooper et al., 2015; Wieczorek, 2018).
Recent large‐scale genome sequencing initiatives of ID 
have identified a diverse set of genes that are predominantly 
impacted by de novo or rare, inherited, clinically relevant 
variants (single‐nucleotide variants [SNVs], indel, CNVs 
(Gilissen et al., 2014; Hu et al., 2016; Uddin, Sturge, Peddle, 
O'Rielly, & Rahman, 2011)). Mutations in these genes are 
often pleiotropic, and associated with a spectrum of neuro-
psychiatric and medical disorders. For example, mutations in 
STXBP1 (OMIM 602926) and CHD8 (OMIM 610528), and 
microdeletions in 15q13.3 and 22q11.2 are all reported to be 
characterized by a range of disorders, and such pleiotropy 
does seem to be typical of other genes implicated in brain 
disorders (Cheung et al., 2014; McCarthy et al., 2014; Uddin 
et al., 2017). A significant number of recessive candidate 
genes have also been identified in consanguineous families 
(Alazami et al., 2015).
Currently, chromosomal microarray (CMA) is the first‐tier 
diagnostic test, which can detect “clinically relevant” variants 
in 25% of individuals with neurodevelopmental disorders 
(including ID) defined as those variants that are pathogenic, 
likely pathogenic, or of unknown significance (variant of un-
certain significance [VUS]) (Ho et al., 2016). The diagnostic 
yield from next‐generation sequencing (whole‐exome or ge-
nome sequencing) was recently reported to be 40%, making it 
a better choice for clinical diagnosis (Lavillaureix et al., 2017; 
Wright et al., 2018). Improvements in identifying smaller 
DNA structural variants, the contribution of mosaic mutations 
(Lim et al., 2017), and better characterization of VUS and in-
tronic mutations will further increase the diagnostic yield.
Results: Here we present two siblings who are both impacted by a large terminal 
duplication and a deletion. Whole‐genome microarray revealed an 18.82 megabase 
(MB) duplication at terminal locus (7q34‐q36.3) of chromosome 7 and a 3.90 MB de-
letion impacting the terminal locus (15q26.3) of chromosome 15. qPCR and ddPCR 
experiments confirmed the de novo origin of the variants and the co‐occurrence of 
these two de novo events among the siblings, but their absence in both parents, impli-
cates an unbalanced translocation that could have mal‐segregated among the siblings 
or a possible germline mosaicism. These terminal events impact IGF1R, CNTNAP2, 
and DPP6, shown to be strongly associated with neurodevelopmental disorders. 
Detailed clinical examination of the siblings revealed the presence of both shared and 
distinct phenotypic features.
Conclusions: This study identified two large rare terminal de novo events impacting 
two siblings. Further phenotypic investigation highlights that even in the presence of 
identical large high penetrant variants, spectrum of clinical features can be different 
between the siblings.
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   | 3 of 9RAHMAN et Al.
Collective evidence from large‐scale independent studies 
has implicated more than 100 genes with ID (Hu et al., 2016, 
2018). This large number of genes are involved in a diverse 
set of pathways and processes. These large number of genes 
and pathways, complicates genotype–phenotype relation-
ship. Synaptic morphology has been implicated in numerous 
ID and neurodevelopmental disorder studies (Zoghbi & Bear, 
2012), and deficits in dendritic arborization, pre‐ or postsyn-
aptic density, and action potential propagation (and hence 
neurotransmitter release) have been shown to be associated 
with ID (Al Shehhi et al., 2018; Bhalla et al., 2008; Rump et 
al., 2016; Woodbury‐Smith et al., 2017). Additionally, genes 
that encode proteins which regulate cytoskeleton dynamics 
have been implicated in ID, including GTP/GDP‐bound state 
of RhoGTPases, such as AP1S2 (OMIM 300629), FGD1 
(OMIM 300546), and SRGAP3 (OMIM 606525). Covalent 
modifications on DNA or posttranslational modifications on 
histones, known as epigenetic regulation, have been well as-
sociated with ID (Bowling et al., 2017).
In this study, we have applied whole‐genome microarray 
to investigate the genetic etiology of two siblings affected 
with ID and facial abnormalities.
2 |  MATERIALS AND METHODS
2.1 | Ethical compliance and sample 
collection
The institutional ethical review committee (IERC) of Holy 
Family Red Crescent Medical College & Hospital, Dhaka, 
Bangladesh approved this study. We have analyzed a non‐
consanguineous quartet family in which the two siblings 
have ID. Informed consent was obtained from the parents of 
the siblings in this study.
2.2 | Clinical assessment
The two siblings were assessed at NeuroGen Technologies Ltd. 
Clinical evaluation included neurological and neurodevelop-
mental assessment by a neurologist and other clinicians. Formal 
parental interviews were undertaken and the siblings were ex-
amined. Information regarding their developmental history was 
collected, including medical history, history of infections, and 
dietary details. Physical examination, including morphometric 
assessment, was performed. More formal psychometric assess-
ment of intellectual development was also carried out using the 
Wechsler Intelligence Scale for Children (WISC). Computerized 
tomography (CT) was also conducted on both siblings.
2.3 | Whole‐genome microarray
We conducted genome‐wide microarray to identify chromo-
somal abnormalities (deletion/duplication/translocation and 
rearrangements) and investigated the changes in fluorescence 
intensities between the test specimen and the controls. Array 
comparative genomic hybridization (aCGH) chip technology 
was applied in Agilent system to detect chromosomal abnor-
malities. This microarray uses 33,000 probes spread across 
the genome to detect 372 genetic abnormalities (includes >60 
loci in DECIPHER database reported for neurodevelopmen-
tal disorders) and also targets 41 subtelomeric regions that 
are vulnerable to chromosomal abnormalities. We have used 
rigorous multiple algorithmic techniques (MatLab and Java) 
and manual curation of the data to pinpoint genomic varia-
tion based on the normalized log2 intensities of the probes. 
Circular binary segmentation algorithm was used on the nor-
malized –log2 values to detect CNVs. Our algorithm excludes 
all common CNVs found in our in‐house (NeuroGen) control 
population samples (9,610 samples) from analysis and only 
analyzed rare CNVs to infer their contribution to human dis-
eases. Digestion, ligation, PCR, labeling, hybridization, and 
scanning were performed following standard protocols.
2.4 | DNA extraction and qPCR experiment
DNA was extracted from peripheral blood sample using 
ReliaPrep™ Blood gDNA isolation kit (Promega) followed 
by the protocols provided by the manufacturer. The con-
centration and quality of DNA were measured using Nano 
Photometer C40 (Implen). Purified gDNA was quantified 
and diluted into 1 ng/µl to make sure that equal amounts of 
DNA in all wells and three replicates of reactions and NTC 
(no template control) were included. We identified two con-
straint genes (infrequent CNVs in normal population) within 
the duplication and deletion breakpoints to validate the chro-
mosomal events. Two Taqman probes were ordered from 
ThermoFisher Scientific, CNTNAP2 (NG_007092.3) (7q34‐
q36.3 duplication), and MEF2A (NC_000015.10) (15q26.3 
deletion). Taqman copy number reference assay RNase P 
(Part Number. 4403326, ThermoFisher Scientific) was also 
ordered. Taqman Universal Master Mix II with UNG (Part 
Number. 4440038, ThermoFisher Scientific) was used for the 
entire assay. Three different reaction mixes were prepared 
as follows for three assays. Taqman Universal Mater Mix II 
with UNG 10 µl, Taqman Copy number assay 20X 1 µl for 
each assays, Taqman Copy Number Reference Assay RNaseP 
20X 1 µl, gDNA (1 ng/1 µl) 6 µl each, Nuclease free water 
2 µl to a total of 20 µl reaction. Samples were prepared in a 
96‐well plate in triplicates and performed the Standard Curve 
experiment the thermal profiles as 95°C for 10  min Hold, 
and to denature 95°C for 15 s, Anneal/Extend 60°C for 60 s 
for 40 cycles run. QuantStudio5 (ThermoFisher Scientific) 
qPCR machine was used to perform the experiment. After the 
run, the data were exported to text file and imported in Copy 
Caller Software Version 2.1 for the analysis of copy number 
variation data using Taqman Copy number assays.
4 of 9 |   RAHMAN et Al.
2.5 | Droplet digital PCR
ddPCR was carried out using QX 200 system (Bio‐Rad 
Laboratories, Inc.). The PCR mixtures–22  µl for each 
sample–were designed to assess copy number variation of 
CNTNAP2 and MEF2A (TaqMan assay, Hs04975510_cn, 
and Hs05329359_cn, ThermoFisher), both genes were 
assayed on FAM channel, whereas the reference gene 
(TaqMan RNase P RPPH1, 14q11.2, ThermoFisher) was as-
sayed on VIC channel. Reaction mixes contained 1X ddPCR 
Supermix (Bio‐Rad). Around 66 ng/reaction of DNA sam-
ples were added without enzymatic digestion. The PCR 
mixtures were partitioned using droplet generator, and then 
transferred into 96‐well PCR plate, the plate was run on the 
thermocycler following the manufacturer's protocol. Data 
analysis and acquisition were performed using QuantSoft 
software version 1.7.4.0917, which measures the number of 
positive and negative droplets. As a next step, the concentra-
tions of the targets as copies/µl were determined by Poisson 
algorithm.
2.6 | Candidate gene and pathway analysis
We applied multiple methods to identify candidate genes 
within the terminal duplication and deletion breakpoint. 
First, the “critical‐exon” method was applied, which iden-
tifies a set of constrained genes, that is, those that have 
exons with a low deleterious mutation burden in the popu-
lation and high expression in the brain compared to other 
tissues (Uddin et al., 2016, 2014). Second, we identified 
genes that have been previously reported (from large‐scale 
sequencing cohorts) to carry de novo mutations (SNVs, 
Indels) or rare CNVs in multiple cases with broader neu-
rodevelopmental disorders (i.e., ASD, ID). To obtain the 
brain expression level of the impacted gene, we analyzed 
523 brain samples (prenatal to adult) RNA‐sequencing 
RPKM data (Kang et al., 2011). The candidate genes were 
analyzed for pathway enrichment using the Gene Ontology 
Panther classification tool (Mi et al., 2017). Well‐curated 
Gene Ontology pathways were analyzed for gene enrich-
ment and a pathway was considered to be significant if the 
false discovery rate (FDR) threshold was <0.01.
3 |  RESULTS
3.1 | Clinical phenotypes
Among the two siblings, the proband is a 7‐year‐old boy, 
who presented with global developmental delay and severely 
impaired language was diagnosed with a moderate ID (Full 
scale IQ: 50) (Figure 1a). He is the first born child to a non‐
consanguineous parents with no family history of neurodevel-
opmental disorders. Following a normal, uncomplicated, and 
healthy pregnancy, he was delivered by lower uterine cesarean 
section (LUCS) following the identification of oligohydram-
nios. Hypotonia and subsequent delay in language and motor 
milestones were observed. He was not walking independently 
until the age of 6 years. There was no history of seizures, or 
any aggressive or other behavioral issues, although he exhib-
ited sensory vulnerabilities. There was no evidence of ASD. 
Further examination revealed abnormal facial appearance with 
depressed nasal bridge, squint, hypertelorism, low set ear, and 
short stature (Figure 1b). His height, weight, and head circum-
ference were 96 cm height‐for‐age Z score (HAZ = −4.90), 
12  kg weight‐for‐age Z score (WAZ  =  −6.83), and 49  cm 
(Z‐score = −2.12), respectively. Vision, hearing, renal, gastro 
were normal and CT scan report was normal.
The affected sibling of the proband is a 4‐year‐old girl who 
also presented with global developmental delay with severely 
impaired language, and was diagnosed with ID. She did not co‐
operate with IQ testing. She was full‐term delivered by LUCS 
following an uneventful pregnancy. She did not communicate 
verbally, and exhibited poor eye contact and nonverbal com-
munication. She was hypotonic and did not crawl (Figure 1b). 
There was no history of seizures, and no behavioral abnormal-
ities. There was no evidence of ASD. On examination, she 
had an abnormal facial appearance with low philtrum, squint, 
inverted v‐shaped thin upper lip, and microcephaly (occipitof-
rontal head circumference = 44 cm, Z‐score = −5.75). On ex-
amination, her height and weight were 86 cm (HAZ = −3.60) 
and 8.5 Kg (WAZ = −6.93), respectively. Vision and hearing 
were normal, and a CT scan was reported as normal.
No abnormalities were detected in GIT (gastrointestinal 
tract), renal, and cardiovascular system in both siblings.
3.2 | Microarray analysis and validation
A pathogenic terminal duplication and deletion, with iden-
tical breakpoints, were detected in both siblings at 7q34‐
q36.3 and 15q26.3 loci, respectively. The first variant is 
an 18.82 megabase (MB) duplication (Chr7: 140,518,420–
159,345,972) impacting more than 100 genes. The second var-
iant is a 3.90 MB deletion (chr15:98,085,693–101,991,189) 
impacting over 30 genes (Figure 1c). These CNVs impact 
the entire subtelomeric regions of chromosome 7 and 15. 
For validation, we applied qPCR probes targeting CNV con-
straint genes CNTNAP2 and MEF2A in chromosome 7 and 
15, respectively. The qPCR analysis showed (in all three rep-
licates) that both variants are de novo in origin.
Based on the ddPCR, automatic thresholding determined 
the copy numbers, and it populated the droplets into four dis-
tinct groups. For some samples, the fluorescence amplitude 
threshold was set manually as a midpoint average. The aver-
age number of accepted droplets ranged from 9,825 to 11,618 
droplets for the MEF2A, and from 8,972 to 16,053 droplets 
for the CNTNAP2. We used exclusion criteria on the basis of 
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(a) total number of droplets <5,000 and (b) the fluorescence 
amplitude was significantly deviated from those of the same 
patients.
Both parents replica samples yielded copy number close 
to two (Figure 1d), which is the expected result for a normal 
diploid genome. On the other hand, ddPCR confirmed the 
copy number variation of both tested genes in both siblings 
which was in agreement with the qPCR results.
3.3 | Candidate gene analysis
Our Gene Ontology pathway enrichment analysis of the im-
pacted genes within the CNV breakpoints identified “detec-
tion of chemical stimulus involved in sensory perception 
(GO:0050907)” and “nervous system process” (GO:0050877) 
pathways to be highly significant (FDR P < 2.1 × 10–6) and 
(FDR P  <  9.0  ×  10–3) after correction. Next, using “criti-
cal‐exon” analysis in conjunction with previously identified 
candidate genes, the following genes (from both loci) were 
considered potential candidates for the phenotypes observed in 
these siblings: FAM131B, CNTNAP2, CUL1, CDK5, AGAP3, 
ABCF2, DPP6, DNAJB6, and PTPRN2 (Figure 2a). Next, we 
have identified IGF1R, UBE3C, KMT2C, EPHB6, TRPV5, 
ESYT2, DPP6, PTPRN2, and CNTNAP2 reported to have de 
novo mutations in multiple (more than 2) independent cases 
with neurodevelopmental disorders, including ASD. The ex-
pression pattern (Figure 2b) of the candidate genes showed sig-
nificantly high expression compared to all genes impacted by 
the two de novo CNVs.
4 |  DISCUSSION
Subtelomeric mutations are an infrequent cause of ID in 
approximately 0.5% of ID cases (Ruiter et al., 2007). The 
co‐occurrence of these two large terminal de novo CNVs in 
F I G U R E  1  (a) The family pedigree with two affected siblings carrying the terminal de novo deletion and duplication. (b) Physical 
characteristic showing hypotonia and facial dysmorphism. (c) The probe intensities (−log2 ratio) of the 18.82 megabase (MB) subtelomeric 
duplication at 7q34‐q36.3 loci and the 3.9 MB deletion at 15q26.3 locus. (d) ddPCR results confirming de novo origin of the two variants. Two 
probes (targeting MEF2A and CNTNAP2) were used and tested in two technical replicates where label refers as F‐father, P‐proband, S‐affected 
sibling, M‐mother
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ID or broader developmental disorders cases is extremely 
rare. Moreover, the co‐occurrence of the two identical de 
novo events suggests either a gonadal mosaicism or a bal-
anced translocation. Subtelomeric deletions of the 15q26.3 
locus have been reported before as a causal variant for de-
velopmental disorders (O'Riordan et al., 2017). The 7q34‐
q36.3 duplication, which affects more than 100 genes, 
might have also contribute to the phenotype, but less is 
known about the phenotypic consequences of duplications 
at this locus, particularly considering how large it is. Our 
Gene Ontology analysis suggests that these terminal CNVs 
are enriched with genes in the pathways for chemical stim-
ulation, sensory perception, and nervous system processes.
We conducted an overlap analysis for the large duplica-
tion with known genomic disorders in mutation databases, 
and identified that it overlaps with variants previously im-
plicated in Weaver syndrome, Noonan syndrome, Jeune 
syndrome, global developmental delay, and ASD. Previous 
reports of terminal duplications of various lengths within 7q 
have also been described in cases with severe to moderate 
F I G U R E  2  (a) The chromosomal location of the candidate genes within the deletion and duplication breakpoint. (b) The boxplot refers to 
human developmental brain expression (RPKM from RNA‐seq) level of 15 candidate genes. The blue line refers to the average expression level of 
all genes impacted by the two de novo copy number variants
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facial dysmorphism and ID (Bartsch, Kalbe, Ngo, Lettau, & 
Schwinger, 1990; Morava et al., 2003; Romain et al., 1990; 
Speleman et al., 2000). It is therefore quite likely that this 
CNV is important in the pathogenesis of the phenotypes ob-
served in these two siblings.
Both loci include multiple potential candidate genes, in-
cluding IGF1R, CNTNAP2, and DPP6, all are well‐studied 
genes that are strongly associated with developmental and 
speech delays, congenital heart disease, epilepsy, diaphrag-
matic hernia, renal anomalies, and ID (Lin et al., 2013; 
Penagarikano et al., 2011; Yang et al., 2018). These candidate 
genes show significantly high expression in the developing 
human brain compared to other genes within the breakpoint 
(Figure 2b). Some of these other genes may be important for 
other phenotypes. For example, SELENOS, SNRPA1, and 
PCSK6 may have a role in the development of the heart.
The clinical observation of both siblings identified similar and 
some unique features. The divot upper lip and low IQ score iden-
tifies the girl in severe spectrum of phenotypes compared to her 
brother. Her inability to crawl or talk at this age was marked as a 
difference compared to her affected brother. There can be multi-
ple sources of risk factors that can explain the phenotypic hetero-
geneity between the siblings. Apart from these two high penetrant 
variants, genetic background, epigenetic factors, sex‐mediated 
factors, and environment also can influence the overall risk factor. 
Moreover, the relative roles of these two CNVs, and, specifically, 
whether a “two hit” mechanism is involved, are also unclear.
The phenotype for 15q26.3 subterminal deletions is highly 
heterogeneous and strongly associated with impaired prenatal and 
postnatal growth, developmental delay, dysmorphic features, and 
skeletal abnormalities. We could not find a recurrent breakpoint 
for the deletion in the DECIPHER database as well as in the liter-
ature. Similarly, there is no case in the literature with a recurrent 
or similar duplication breakpoint at 7q34‐q36.3 loci. Subtelomeric 
regions are more susceptible to aberrant rearrangements than other 
chromosomal regions (Brown et al., 2001; Saccone, De Sario, 
Della Valle, & Bernardi, 1992; Uddin et al., 2011). A large‐scale 
study carried out on submicroscopic subtelomeric aberrations in 
Chinese patients found that this chromosomal rearrangement im-
pact 5.1% of children with clinically unexplained ID (Wu et al., 
2010). Phenotypic manifestations usually depend on the number 
of genes involved (Helias‐Rodzewicz et al., 2002). Some common 
clinical feature may suggest various subtelomeric abnormalities 
including family history of ID, prenatal onset of growth retarda-
tion, postnatal growth abnormalities, at least two facial dysmor-
phic features, and at least one nonfacial dysmorphic feature and/or 
congenital abnormality (de Vries et al., 2001).
5 |  CONCLUSIONS
In this study, we have presented two siblings with two novel 
genomic rearrangements that are extremely rare. Both variants 
are de novo and high penetrant, impacting many important 
genes that are involved in neurodevelopmental processes. The 
co‐occurrence of more than one de novo event is extremely 
rare and suggestive of gonadal mosaicism. Although these 
variants are large and pathogenic, the phenotypes of the two 
siblings comprise similarities and differences. In order to vali-
date our conclusion, we conducted ddPCR on the constraint 
genes and we demonstrated a normal diploid genomic DNA in 
parents. To unravel the mechanisms of genotype–phenotype 
differences between siblings with identical mutations, would 
require more detailed molecular experiments and modeling for 
epigenetic and other factors. Additionally, the detailed phe-
notype–genotype study of individual families, such as ours, 
will continue to be crucial in the identification of new, rare ID 
genes, and through the accumulation of evidence, the unique 
and shared patterns of phenotype will spurn new hypotheses 
concerning exact brain‐behavior mechanisms for these debili-
tating disorders.
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